Cannabinoid receptor agonist; synthetic, nonpsychoactive derivative of Δ9-tetrahydrocannabinol, q.v. Prepn: S. H. Burstein et al., J. Med. Chem. 35, 3135 (1992); S. H. Burstein, R. Mechoulam, WO 9401429; eidem, US 5338753 (both 1994). GC-MS determn in plasma: C. Batista et al., J. Chromatogr. B 820, 77 (2005). Binding to CB-receptors: M.-H. Rhee et al., J. Med. Chem. 40, 3228 (1997); to PPARγ receptor: J. Liu et al., Mol. Pharmacol. 63, 983 (2003). Clinical evaluation in chronic neuropathic pain: M. Karst et al., J. Am. Med. Assoc. 290, 1757 (2003). Reviews of development and pharmacology: S. Burstein et al., Life Sci. 75, 1513-1522 (2004); idem, AAPS J. 7, E143-E148 (2005); J. L. Wiley, IDrugs 8, 1002-1011 (2005).
Anti-inflammatory.
Anti-inflammatory (Nonsteroidal)